Pharmacosmos
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
120 Headquarters Plaza Fl 6 East Tower, ...Phone Number
(908) 769-7100Website
www.pharmacosmos.usRevenue
$40.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Pharmacosmos
Pharmacosmos Therapeutics Inc. is a United States specialty pharmaceutical company and the American affiliate of Denmark-based Pharmacosmos, a family-owned international healthcare company founded in 1965. The company specializes in the treatment of iron deficiency and iron deficiency anemia, focusing primarily on the prescription iron pharmaceutical market which represents two-thirds of its revenue. Pharmacosmos Therapeutics commercializes Monoferric, a high-dose intravenous iron treatment marketed in the United States, and provides exceptional resources to support patient care. The parent company Pharmacosmos is recognized as a global pioneer in carbohydrate chemistry and a world leader in iron therapy, with corporate headquarters, manufacturing facilities, and research laboratories located in Holbaek, Denmark. The company develops, manufactures, and markets medicines for treating iron deficiency anemia in humans and animals, while also specializing in developing and producing advancRead more
Pharmacosmos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharmacosmos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Pharmacosmos has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Pharmacosmos
Funding: Get notified immidiatlly once Pharmacosmos has new funding data
Earning: See what the market has to say on Pharmacosmos recently announced quarterly report
Pharmacosmos, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Pharmacosmos launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Pharmacosmos is spiking on competitors!
Click to see if Pharmacosmos had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Pharmacosmos is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pharmacosmos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pharmacosmos.
Pharmacosmos Tech Stack
A closer look at the technologies used by Pharmacosmos
Most Recent Scoops
Open Position
Open Position
Open Position
Event
Events
Open Position
Pharmacosmos News & Media
Menarini Asia-Pacific partners with Pharmacosmos to expand its reach of MonoFer® to Singapore and Malaysia
SINGAPORE, June 19, 2024 /PRNewswire/ -- Menarini Asia-Pacific (Menarini) today announced that it has expanded its partnership with Pharmacosmos A/S (Pharmacosmos), to include exclusive rights to commercialise MonoFer® (ferric derisomaltose) in Singapore and Malaysia. This builds upon the successful collaboration between the companies for MonoFer® in Australia. Menarini will manage all aspects of MonoFer®'s marketing, sales and distribution in Singapore and Malaysia. MonoFer® is an innovative hiPharmacosmos Group Acquires Boston Based Clinical Stage AbFero Pharmaceuticals, Inc.
HOLBAEK, Denmark, Nov. 11, 2021 /PRNewswire/ -- Pharmacosmos Group, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, today announced the acquisition of AbFero Pharmaceuticals, Inc., a Boston based, privately-held...Intravenous (IV) Iron Drugs 2018: Global Strategic Business Outlook to 2024 - Expanding Pool of ESRD and CKD Patients: The Major Growth Driver
Dublin, July 03, 2018 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Iron Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmacosmos
Sign Up For FreeTo access detailed company insights
Pharmacosmos Therapeutics Inc. is a United States specialty pharmaceutical company and the American affiliate of Denmark-based Pharmacosmos, a family-owned international healthcare company founded in 1965. The company specializes in the treatment of iron deficiency and iron deficiency anemia, focusing primarily on the prescription iron pharmaceutic... Read More
